COMUNICADO: Experts Predict Tamiflu Could Halve the Pandemic Influenza Death Toll Versus no Intervention (y 2)

Actualizado 22/06/2007 3:04:37 CET

Headquartered in Basel, Switzerland, Roche is one of the world's leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics. As the world's biggest biotech company and an innovator of products and services for the early detection, prevention, diagnosis and treatment of diseases, the Group contributes on a broad range of fronts to improving people's health and quality of life. Roche is the world leader in in-vitro diagnostics and drugs for cancer and transplantation, a market leader in virology and active in other major therapeutic areas such as autoimmune diseases, inflammation, metabolism and central nervous system.

Additional information

-- Roche Health Kiosk, Influenza: www.health-kiosk.ch/start_grip.htm

-- About Tamiflu: www.roche.com/med_mbtamiflu05e.pdf

-- About influenza: www.roche.com/med_mbinfluenza05e.pdf

-- WHO: Global influenza programme: www.who.int/csr/disease/influenza/en/

-- WHO: Avian flu: www.who.int/mediacentre/factsheets/avian_influenza/en/

References

(1). B Sander et al. Economic Evaluation of Influenza Pandemic Mitigation Strategies in the US Using a Stochastic Microsimulation Influenza Model. Data presented at OPTIONS VI 2007. (Abstract Tracking Number O82)

(2). Public pandemic plans and media reporting

(3). Germann TC et al. Mitigation strategies for pandemic influenza in the United States, PNAS 2006; 103:5935-5940

(4). Department of Communicable Disease Surveillance and Response, World Health Organisation, WHO Guidelines on the Use of Vaccines and Antivirals during Influenza Pandemics, http://www.who.int/csr/resources/publications/influenza/11_29_01_A.pdf ,Accessed 25 May, 2007

For further information, or to arrange an interview with David Reddy, Global Influenza Pandemic Task Force Leader for Roche, or Professor Monto, University of Michigan, please contact:


Onsite in Toronto:
Helen Walicka, Roche, +41-79-263-9701
Peter Impey, Ketchum, +44-79-7673-4493
Office: Lucy Rispin, Ketchum, +44-207-611-3621 / +44-77-8991-4901

For further information, or to arrange an interview with David Reddy, Global Influenza Pandemic Task Force Leader for Roche, or Professor Monto, University of Michigan, please contact: Onsite in Toronto: Helen Walicka, Roche, +41-79-263-9701; Peter Impey, Ketchum, +44-79-7673-4493; Office: Lucy Rispin, Ketchum, +44-207-611-3621 / +44-77-8991-4901

Mejora la comunicación de tu empresa con Europa Press Comunicación

Esta web utiliza cookies propias y de terceros para analizar su navegación y ofrecerle un servicio más personalizado y publicidad acorde a sus intereses. Continuar navegando implica la aceptación de nuestra política de cookies -
Uso de cookies